TY - CHAP M1 - Book, Section TI - Chapter 46. Solid Organ Transplantation A1 - Brady, Rebecca L. A1 - Hall, Reed C. A2 - Attridge, Rebecca L. A2 - Miller, Monica L. A2 - Moote, Rebecca A2 - Ryan, Laurajo PY - 2013 T2 - Internal Medicine: A Guide to Clinical Therapeutics AB - Curative treatment for end-stage organ diseasePrevalence of transplants ↑ with improved surgical techniques, immunosuppression regimens, & disease state management leading up to transplantLiver: chronic noncholestatic liver disorders (most common reasons for transplant)→ chronic HCV, EtOH, chronic HBV; cholestatic liver disorders → primary sclerosing cholangitis (PSC), primary biliary cirrhosis (PBC); other reasons for transplant → metabolic disorders causing cirrhosis, &/or severe extrahepatic morbidity, primary hepatic malignancies, fulminant hepatic failure, retransplant, NASH (nonalcoholic steatohepatitis)Kidney: DM, HTN, GN, PCKD, hypertensive nephrosclerosis, congenital, familial & metabolic diseases, tubular & interstitial diseases, neoplasms, retransplantHeart: CAD, cardiomyopathy, congenital heart disease, valvular heart diseaseLung: emphysema/COPD, cystic fibrosis, idiopathic pulmonary fibrosis, α1-antitrypsin deficiency, idiopathic pulmonary arterial hypertension, congenital diseasePancreas: type 1 DM complicated by severe hypoglycemia unawareness or hyperlabilityIntestine: short gut syndrome, functional bowel problem SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=57295748 ER -